申请人:Heffernan Michele L. R.
公开号:US20100029737A1
公开(公告)日:2010-02-04
The present invention provides novel inhibitors of the enzyme D-amino acid oxidase. The compounds of the invention are useful for treating or preventing diseases and/or condition, wherein modulation of D-serine levels, and/or its oxidative products, is effective in ameliorating symptoms. The invention further provides methods of enhancing learning, memory and/or cognition. For example, the invention provides methods for treating or preventing loss of memory and/or cognition associated with neurodegenerative diseases, such as Alzheimer's disease. The invention further provides methods for preventing loss of neuronal function characteristic of neurodegenerative diseases. In addition, methods are provided for the treatment or prevention of neuropsychiatric diseases (e.g., schizophrenia) and for the treatment or prevention of pain and ataxia.
本发明提供了新型D-氨基酸氧化酶酶的抑制剂。本发明的化合物可用于治疗或预防疾病和/或症状,其中调节D-丝氨酸水平和/或其氧化产物对缓解症状有效。本发明还提供了增强学习,记忆和/或认知的方法。例如,本发明提供了用于治疗或预防神经退行性疾病(如阿尔茨海默病)相关的记忆和/或认知丧失的方法。本发明还提供了预防神经退行性疾病特征性神经元功能丧失的方法。此外,还提供了用于治疗或预防神经精神疾病(例如,精神分裂症)和用于治疗或预防疼痛和共济失调的方法。